Cardioprotective pharmacotherapy in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail

Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on markers of neurohumoral activation and left atrial strain.

Doctor I. Ikonomidis (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Incident cardiovascular disease in women with type 1 or type 2 diabetes by history of hypertensive disorders of pregnancy

Associate Professor S. Timpka (Malmo, SE)

Abstract Slides Video

Presentation thumbnail

Change in hbA1c following treatment with and the short-term risk of major adverse cardiovascular outcomes

Mrs B. Zareini (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

The prognostic value of high-sensitivity cardiac troponin t in diabetes patients without coronary artery disease

Mr Y. He (Guangzhou, CN)

Abstract Slides Video

Presentation thumbnail

Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment.

Doctor I. Ikonomidis (Athens, GR)

Abstract Slides Video

Access the full session

Session thumbnail

Diabetes and the heart (1)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Presentation

Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting

Congress Presentation

Cardiovascular risk reduction: should we target pre-diabetes?

Webinar

Prevention of heart failure in diabetic patients at population level

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources